NASDAQ: SRDX
Surmodics Inc Stock

$34.10-0.06 (-0.18%)
Updated Feb 14, 2025
SRDX Price
$34.10
Fair Value Price
$0.85
Market Cap
$487.49M
52 Week Low
$25.17
52 Week High
$42.44
P/E
-33.43x
P/B
4.36x
P/S
4.49x
PEG
N/A
Dividend Yield
N/A
Revenue
$125.45M
Earnings
-$14.41M
Gross Margin
74.8%
Operating Margin
-4.94%
Profit Margin
-11.5%
Debt to Equity
0.47
Operating Cash Flow
$1M
Beta
0.94
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

SRDX Overview

Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device segment engages in the provision of surface modification coating technologies to enhance access, deliverability, and predictable deployment of medical devices; and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device for coronary, peripheral, neuro-vascular and structural heart, and other markets, as well as design, development, and manufacturing of interventional medical devices, primarily balloons and catheters, including drug-coated balloons for peripheral arterial disease treatment and other applications. The IVD segment designs, develops, and manufactures component products and technologies for diagnostic immunoassay, as well as molecular test and biomedical research applications. This segment offers protein stabilization reagents, substrates, surface coatings, and antigens. The company was founded in 1979 and is headquartered in Eden Prairie, Minnesota.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine SRDX's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

C
Value
C
Growth
C
Momentum
C
Sentiment
B
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Medical Device

Industry Rating
D
SRDX
Ranked
#45 of 129

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$31.89A
$10.41A
$47.68A
View Top Medical Device Stocks

Be the first to know about important SRDX news, forecast changes, insider trades & much more!

SRDX News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SRDX scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SRDX ($34.10) is overvalued by 3,917.8% relative to our estimate of its Fair Value price of $0.85 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
SRDX ($34.10) is not significantly undervalued (3,917.8%) relative to our estimate of its Fair Value price of $0.85 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SRDX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more SRDX due diligence checks available for Premium users.

Valuation

SRDX fair value

Fair Value of SRDX stock based on Discounted Cash Flow (DCF)

Price
$34.10
Fair Value
$0.85
Overvalued by
3,917.80%
SRDX ($34.10) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SRDX ($34.10) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SRDX is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SRDX price to earnings (PE)

For valuing profitable companies with steady earnings

Company
-33.43x
Industry
42.37x
Market
37.92x

SRDX price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
4.36x
Industry
4.36x
SRDX is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SRDX's financial health

Profit margin

Revenue
$29.9M
Net Income
-$3.7M
Profit Margin
-12.2%
SRDX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
SRDX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$163.7M
Liabilities
$52.0M
Debt to equity
0.47
SRDX's short-term assets ($71.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SRDX's short-term assets ($71.85M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SRDX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
SRDX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$7.9M
Investing
$3.7M
Financing
-$1.2M
SRDX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

SRDX vs Medical Device Stocks

TickerZen RatingMarket Cap1d %P/EP/B
SRDXC$487.49M-0.18%-33.43x4.36x
CLPTC$505.35M-0.33%-26.94x17.43x
PACBC$506.65M+25.00%-1.27x1.12x
DCTHB$520.53M0.00%-13.57x60.73x
MXCTC$439.86M+2.46%-12.26x2.06x

Surmodics Stock FAQ

What is Surmodics's quote symbol?

(NASDAQ: SRDX) Surmodics trades on the NASDAQ under the ticker symbol SRDX. Surmodics stock quotes can also be displayed as NASDAQ: SRDX.

If you're new to stock investing, here's how to buy Surmodics stock.

What is the 52 week high and low for Surmodics (NASDAQ: SRDX)?

(NASDAQ: SRDX) Surmodics's 52-week high was $42.44, and its 52-week low was $25.17. It is currently -19.65% from its 52-week high and 35.48% from its 52-week low.

How much is Surmodics stock worth today?

(NASDAQ: SRDX) Surmodics currently has 14,295,998 outstanding shares. With Surmodics stock trading at $34.10 per share, the total value of Surmodics stock (market capitalization) is $487.49M.

Surmodics stock was originally listed at a price of $4.06 in Mar 4, 1998. If you had invested in Surmodics stock at $4.06, your return over the last 26 years would have been 739.28%, for an annualized return of 8.53% (not including any dividends or dividend reinvestments).

How much is Surmodics's stock price per share?

(NASDAQ: SRDX) Surmodics stock price per share is $34.10 today (as of Feb 14, 2025).

What is Surmodics's Market Cap?

(NASDAQ: SRDX) Surmodics's market cap is $487.49M, as of Feb 15, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Surmodics's market cap is calculated by multiplying SRDX's current stock price of $34.10 by SRDX's total outstanding shares of 14,295,998.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.